Mr. Tilton has over 20 years of experience commercializing drug products and leading global pharmaceutical business units. He joined Biohaven from Alexion Pharmaceuticals, Inc. where he was an Executive Director and one of the founding commercial leaders responsible for the commercialization of multiple orphan drug indications.